1,200
Participants
Start Date
July 12, 2022
Primary Completion Date
June 1, 2026
Study Completion Date
June 1, 2027
Survey / Interview Group
Patients with any cancer type who are informed that they may be eligible for participation in any phase therapeutic cancer clinical trial by their treating physician (typically a clinical oncologist) will be provided information about the Financial Reimbursement Program. Patients who enroll to therapeutic cancer clinical trial will be eligible for the reimbursement program and offered an opportunity to participate in this study.
RECRUITING
University of Texas Southwestern Medical Center, Dallas
Cancer Prevention Research Institute of Texas
OTHER
University of Texas Southwestern Medical Center
OTHER